NeuroPace NPCE
NASDAQ NPCE
$7.56 -4.46 (-37.10%)
At close: Nov 13, 2026 · 4:00 PM EST

NeuroPace (NPCE) Gains from Sales and Divestitures (2025)

Updated

NeuroPace's Gains from Sales and Divestitures was -$12,000 in Q4 2025.

Analysis

NeuroPace (NPCE) Gains from Sales and Divestitures (2025) Analysis & Trends

For FY2025, Gains from Sales and Divestitures at NeuroPace came in at -$14,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 NeuroPace 260.31 Mn 44.34 Mn 19.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -12,000.00
Mar 31, 2025 -2,000.00
API Access

NeuroPace Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NPCE&period=max&api_key=YOUR_API_KEY